Hospira Inc

Source:

Campaign Finance

Information

Figures are based on itemized contributions reported to the Federal Election Commission and state agencies. Please note that:

  • contributions under $200 are not reported, and so are not included in totals.
  • only contributions from individuals and organizations to candidates are included. Various accounting measures and more exotic contribution types are excluded.
  • contributions are matched based on organization and recipient name reported within each election cycle. Contributions using an incorrect or non-standard version of the name may be missed.
  • corporate name changes and mergers may cause figures to differ from those of the Center for Responsive Politics.
  • organization totals include known subsidiaries of the organization.

For more information, please see our campaign finance methodology page. Lobbyist bundling data is described on our lobbyist bundling methodology page.

Latest FEC Data

covers through committee's June 30, 2012 filing.
Download all contributions to Hospira Inc

  • Summary

    overview of the committee's finances
    Total Raised:
    $165,868
    Total Spent:
    $176,790
    Cash on Hand:
    $52,129
    Debts:
    $0

Standardized Donation Information

covers through 2011. may lag behind FEC section above, as donors and industries are identified by hand.

  • Top Recipients

    Employee Color Block
    Individuals
    PAC Color Block
    PAC
    Includes contributions from the organization’s employees, their family members, and its political action committee.

  • Republicans vs. Democrats

    in dollars

  • State vs. Federal

    in dollars

  • Top PAC Recipients

    Employee Color Block
    Individuals
    PAC Color Block
    PAC
    Includes contributions from the organization’s employees, their family members, and its political action committee.
View all campaign finance data for Hospira Inc Sources: OpenSecrets.org

Lobbying

$500,000 Spent
Information

Figures are based on lobbying activity reported to the Senate Office of Public Records. Reported dollar amounts are required to be accurate only to the nearest $20,000. For organizations whose primary business is lobbying, we display total income and top clients. For organizations that are not primarily lobbying firms, we display total amount spent on lobbying and top lobbying firms hired.

For more information, please see our lobbying methodology page.

covers through Q3, 2011

Lobbying On Behalf of Hospira Inc

View all lobbying data for Hospira Inc Sources: Lobbyist Registration Tracker OpenSecrets.org

Regulations

12 Mentions; 4 Submissions
Information

All data is based on documents downloaded from Regulations.gov. The first table shows mentions: all documents that include the name of the company anywhere in the document or document metadata. The second table shows submissions: all documents where the submitter metadata included the company name. Each table shows the top 10 dockets, ranked by number of occurrences.

Matches are based on a search for the company name. Variations in the company name, such as acronyms, nicknames or alternate names may cause documents to be missed. The mention of a company name in a document may be incidental and does not necessarily indicate that the company has any relevance to the document. Company names that are common English words may erroneously match with text that is not referring to the company.

Not all agencies submit public comments to Regulations.gov. For a list of participating and non-participating agencies see here. Agencies that do submit to Regulations.gov have varying levels of accuracy and completeness.

Regulations and public comments can be downloaded in bulk here.

updated from Regulations.gov on September 27, 2011

The tables show occurrences of "Hospira Inc" in public comments on proposed federal regulations.

  • Documents Submitted by the Organization
    • Submissions
    • Agency
    • Docket
    • Date
    • Toggle 1 FDA Designate Sandoz ANDA 065204 as a Reference Listed Drug for Purposes of Submitting an ANDA for a Generic Version of This Product 2011
    • Toggle 1 CDC Draft Action Plan – A Public Health Action Plan to Combat Antimicrobial- Resistance 2011
    • Toggle 1 FDA Biologics Price Competition and Innovation Act of 2009; Options for a User Fee Program for Biosimilar and Interchangeable Biological Product Applications for Fiscal Years 2013 through 2017; Request for Comments 2011
    • Toggle 1 FDA Designate Sanofi-Aventis Drug Product, CLAFORAN® (Cefotazime for Injection) 1g and 2g in ADD-Vantage® Vial for Purposes of Submitting an Abbreviated New Drug Application (ANDA) 2011
  • Mentions in Document Text
    • Mentions
    • Agency
    • Docket
    • Date
    • Toggle 3 FDA Designate Sandoz ANDA 065204 as a Reference Listed Drug for Purposes of Submitting an ANDA for a Generic Version of This Product 2011
    • Toggle 2 FDA Designate Sanofi-Aventis Drug Product, CLAFORAN® (Cefotazime for Injection) 1g and 2g in ADD-Vantage® Vial for Purposes of Submitting an Abbreviated New Drug Application (ANDA) 2011
    • Toggle 1 ITC Meetings; Sunshine Act 2011
    • Toggle 1 FDA Bristol-Myers Squibb Co. et al.; Withdrawal of Approval of 70 New Drug Applications and 97 Abbreviated New Drug Applications - CLOSED 2011
    • Toggle 1 JBEA Meetings: Advisory Committee 2011
    • Toggle 1 ITC Complaints: Certain Gemcitabine and Products Containing Same 2011
    • Toggle 1 ITC Terminations of Investigations: Certain Gemcitabine And Products Containing Same 2011
    • Toggle 1 FTC Proposed Consent Agreements: Hikma Pharmaceuticals PLC; Analysis of Agreement Containing Consent Orders To Aid Public Comment 2011
    • Toggle 1 FDA Biologics Price Competition and Innovation Act of 2009; Options for a User Fee Program for Biosimilar and Interchangeable Biological Product Applications for Fiscal Years 2013 through 2017; Request for Comments 2011
    • Toggle 1 ITC Institution of Formal Enforcement Proceedings: Certain DC-DC Controllers and Products Containing Same 2011

Advisory Committees

1 person on 1 committee
Information

Data is based on disclosures required by the Federal Advisory Committee Act (FACA). Matches are based on the occurrence of the company name in the committee member affiliation. Variations in company names may cause some matches to be missed.

The table shows only the top 10 agencies. To search and download raw records from the complete dataset see the FACA data section.

covers through 2011

Table shows employees of "Hospira Inc" that sat on federal advisory committees.

  • Agency
  • Representation
  • Toggle Department of Health and Human Services 1 person on 1 committee
View all advisory committee data for Hospira Inc